Cuijian Yang is an accomplished inventor based in Collegeville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of estrogen receptor modulators. With a total of three patents to his name, Yang's work has the potential to impact various therapeutic applications.

Latest Patents

Yang's latest patents include "Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents." This invention provides estrogen receptor modulators with a specific structure, which can be utilized as a pharmaceutically acceptable salt. Another notable patent is "Substituted phenyl naphthalenes as estrogenic agents," which offers estrogen receptor modulators of a defined formula, further advancing the understanding of estrogenic activity.

Career Highlights

Cuijian Yang is associated with Wyeth, a prominent company in the pharmaceutical industry. His work at Wyeth has allowed him to focus on innovative research and development in the field of estrogenic agents. His contributions have been instrumental in enhancing the understanding of estrogen receptor modulation.

Collaborations

Yang has collaborated with notable colleagues, including Richard Eric Mewshaw and Richard J Edsall. These collaborations have fostered a productive research environment, leading to advancements in their shared field of expertise.

Conclusion

Cuijian Yang's innovative work in the development of estrogen receptor modulators showcases his dedication to advancing pharmaceutical science. His patents reflect a commitment to improving therapeutic options for various health conditions.

This text is generated by artificial intelligence and may not be accurate.